Cargando…
Therapies Targeted to Androgen Receptor Signaling Axis in Prostate Cancer: Progress, Challenges, and Hope
Prostate cancer is the mostly commonly diagnosed non-cutaneous malignancy and the second leading cause of cancer-related death affecting men in the United States. Moreover, it disproportionately affects the men of African origin, who exhibit significantly greater incidence and mortality as compared...
Autores principales: | Saranyutanon, Sirin, Srivastava, Sanjeev Kumar, Pai, Sachin, Singh, Seema, Singh, Ajay Pratap |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016833/ https://www.ncbi.nlm.nih.gov/pubmed/31877956 http://dx.doi.org/10.3390/cancers12010051 |
Ejemplares similares
-
Cellular and Molecular Progression of Prostate Cancer: Models for Basic and Preclinical Research
por: Saranyutanon, Sirin, et al.
Publicado: (2020) -
Biphasic transcriptional and posttranscriptional regulation of MYB by androgen signaling mediates its growth control in prostate cancer
por: Acharya, Srijan, et al.
Publicado: (2022) -
Biomarker-Based Targeting of the Androgen-Androgen Receptor Axis in Advanced Prostate Cancer
por: Kohli, Manish, et al.
Publicado: (2012) -
The miR-96 and RARγ signaling axis governs androgen signaling and prostate cancer progression
por: Long, Mark D., et al.
Publicado: (2018) -
Androgen receptor signaling in prostate cancer development and progression
por: Lonergan, Peter E, et al.
Publicado: (2011)